BlackRock’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,274,121
| Closed | -$93.7M | – | 5040 |
|
|
2018
Q3 | $93.7M | Buy |
5,274,121
+65,410
| +1% | +$1.16M | ﹤0.01% | 2007 |
|
|
2018
Q2 | $71.9M | Buy |
5,208,711
+3,497,995
| +204% | +$48.3M | ﹤0.01% | 2133 |
|
|
2018
Q1 | $15.6M | Buy |
1,710,716
+571,925
| +50% | +$5.2M | ﹤0.01% | 2877 |
|
|
2017
Q4 | $4.88M | Buy |
1,138,791
+786,933
| +224% | +$3.37M | ﹤0.01% | 3409 |
|
|
2017
Q3 | $497K | Sell |
351,858
-3,742
| -1% | -$5.29K | ﹤0.01% | 3995 |
|
|
2017
Q2 | $534K | Sell |
355,600
-1,654,369
| -82% | -$2.48M | ﹤0.01% | 3950 |
|
|
2017
Q1 | $5.17M | Buy |
2,009,969
+2,001,206
| +22,837% | +$5.14M | ﹤0.01% | 3341 |
|
|
2016
Q4 | $23K | Sell |
8,763
-1,103
| -11% | -$2.9K | ﹤0.01% | 3161 |
|
|
2016
Q3 | $30K | Hold |
9,866
| – | – | ﹤0.01% | 3114 |
|
|
2016
Q2 | $31K | Buy |
9,866
+6,996
| +244% | +$22K | ﹤0.01% | 3093 |
|
|
2016
Q1 | $9K | Buy |
2,870
+1,819
| +173% | +$5.7K | ﹤0.01% | 3168 |
|
|
2015
Q4 | $4K | Hold |
1,051
| – | – | ﹤0.01% | 3191 |
|
|
2015
Q3 | $5K | Hold |
1,051
| – | – | ﹤0.01% | 3017 |
|
|
2015
Q2 | $5K | Hold |
1,051
| – | – | ﹤0.01% | 3093 |
|
|
2015
Q1 | $7K | Hold |
1,051
| – | – | ﹤0.01% | 2915 |
|
|
2014
Q4 | $7K | Hold |
1,051
| – | – | ﹤0.01% | 2949 |
|
|
2014
Q3 | $6K | Hold |
1,051
| – | – | ﹤0.01% | 2992 |
|
|
2014
Q2 | $7K | Buy |
1,051
+226
| +27% | +$1.51K | ﹤0.01% | 2986 |
|
|
2014
Q1 | $20K | Hold |
825
| – | – | ﹤0.01% | 2351 |
|
|
2013
Q4 | $9K | Hold |
825
| – | – | ﹤0.01% | 2776 |
|
|
2013
Q3 | $11K | Hold |
825
| – | – | ﹤0.01% | 2591 |
|
|
2013
Q2 | $11K | Buy |
+825
| New | +$11K | ﹤0.01% | 2603 |
|